常規の臨床試験における,集中発作の制御が不十分な患者におけるブリヴァラセタムの早期追加治療の有効性と安全性
Pedro J Serrano-Castro1,2,3, Fernando Caballero-Martínez4, Francisco J Campos-Lucas5
1Instituto de Investigación Biomédica de Málaga (IBIMA-Plataforma Bionand), Málaga, Spain.
Epilepsia open
|August 30, 2025
まとめ
ブリヴァラセタム (BRV) アドオン療法は,単独治療で不十分に制御された患者の集中発作を効果的に軽減しました. 多くの患者は,好調な耐性で,著しい発作の減少または発作の解消を達成しました.
科学分野:
- 神経学
- エピレプト学
- 薬理学について
背景:
- 焦点発作は,抗発作薬 (ASM) の単独療法にもかかわらず,しばしば持続する.
- ブリヴァラセタム (BRV) は,耐性性の追加治療の選択肢です.
- BRVの実用的な効果と安全性を評価することが重要です.
研究 の 目的:
- ブリヴァラセタム (BRV) の有効性と安全性を評価する.
- ASM単独治療に反応しない焦点発作の患者におけるBRVの評価.
- 常規の臨床実務における発作の減少と自由率を決定する.
主な方法:
- スペインの17の神経学センターで実施された 多中心の観察研究です
- 発作の制御が不十分でASM単独治療を受けた成人患者も含まれていた.
- BRVとASMによる2重治療の6ヶ月後の評価結果
主要な成果:
- 患者の90. 8%が発作頻度を50%以上減少させた.
- 患者の49. 7%が完全無発作になりました.
- 中枢神経系有害事象は22. 1%で,治療中止は12. 8%でした.
結論:
- ブリヴァラセタムは,発作発作の頻度を下げるのに有意な効果を示しています.
- BRVはよく耐受され,臨床実務における補足療法として有効である.
- 耐火性焦点性の患者にとって価値ある選択肢としてBRVをサポートします.
関連する概念動画
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
635
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
635
01:20Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
01:24Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
01:14Antiepileptic Drugs: Glutamate Antagonists
511
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
511
01:13Seizures: Classification
584
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
584